SOCS3 and systemic lupus erythematosus: Using MRL-lpr/lpr mice, a mouse model for SLE, Asari et al. showed that that oral administration of high molecular weight hyaluronan (HA900) inhibited Th1-type autoimmune disease and inflammation by up-regulating SOCS3 expression and down-regulating pleiotrophin expression [27].